when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Endpoints·33m ago·1 min read

Akeso details survival win for its PD-1xVEGF drug versus Keytruda

Sep 13, 2026·read at Endpoints ↗

Akeso and Summit Therapeutics claimed a key win over Keytruda at the start of September, and are now spelling out that survival data. They hope it will add to the trove of results supporting the ...

source

Reporting by Endpoints.

read at Endpoints ↗

sharex / twitter linkedin

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

16h agoSetbacks for Novartis; Anthropic looks for a dealmaker; and moreEndpoints
1d agoFDA extends review of Exelixis' colorectal cancer drug candidateEndpoints
1d agoYarrow brings in more cash; AbbVie drug succeeds in menstrual migraine trialEndpoints
1d agoNew report may spell trouble for future cheaper biologicsEndpoints
1d agoAlzheon outlines plans for major fundraising round despite Phase 3 miss for Alzheimer's drugEndpoints